ArticleHaematologica2021

Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma.

Lorenz Thurner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.